Literature DB >> 30472210

Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics.

Masanori Hara1, Kazuhiko Oohara2, Dao-Fu Dai3, Helen Liapis4.   

Abstract

Mitotic catastrophe (MC) is a major cause of podocyte loss in vitro and in vivo. We evaluated urine samples (n = 184 urine samples from diabetic patients; n = 41 patients) from diabetic patients and determined the presence of podocytes in the urine and studied their characteristics, specifically asking whether apoptosis versus MC is present. We also evaluated diabetic glomeruli in renal biopsy specimens by electron microscopy (n = 54). A battery of stains including the antibody to podocalyxin (PCX) were used. PCX and podocytes (PCX+podo) showed nuclear morphologies such as a i) mononucleated normal shape (8.7%), ii) large and abnormal shape (3.8%), iii) multinucleated with or without micronucleoli (31.2%), iv) mitotic spindles (8.2%), v) single nucleus and denucleation combined (10.3%), and vi) denucleation only (37.0%). Large size/abnormal shape, multinucleation, mitotic spindles, and a combination of single nucleus and denucleation were considered features of MC (53.5%). Dual staining of PCX+podo was positive for Glepp 1 (50%), whereas none of PCX+podo were positive for nephrin, podocin, leukocyte, or parietal epithelial cell markers (cytokeratin 8), annexin V, cleaved caspase-3, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling. Ten percent of PCX+podo were positive for phosphorylated vimentin. Electron microscopy identified cellular and nuclear podocyte changes characteristic of MC. The majority of urine podocytes in diabetic patients showed MC, not apoptosis. This noninvasive approach may be clinically useful in determining progressive diabetic nephropathy or response to therapeutic intervention.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30472210      PMCID: PMC6943371          DOI: 10.1016/j.ajpath.2018.10.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Podocyte number in normotensive type 1 diabetic patients with albuminuria.

Authors:  Kathryn E White; Rudolf W Bilous; Sally M Marshall; Meguid El Nahas; Giuseppe Remuzzi; Giampiero Piras; Salvatore De Cosmo; GianCarlo Viberti
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

Review 2.  New insights into the pathology of podocyte loss: mitotic catastrophe.

Authors:  Helen Liapis; Paola Romagnani; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2013-09-03       Impact factor: 4.307

3.  Urinary podocytes in primary focal segmental glomerulosclerosis.

Authors:  M Hara; T Yanagihara; I Kihara
Journal:  Nephron       Date:  2001-11       Impact factor: 2.847

4.  Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.

Authors:  T W Meyer; P H Bennett; R G Nelson
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

5.  Apoptosis in podocytes induced by TGF-beta and Smad7.

Authors:  M Schiffer; M Bitzer; I S Roberts; J B Kopp; P ten Dijke; P Mundel; E P Böttinger
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  Podocyte loss and progressive glomerular injury in type II diabetes.

Authors:  M E Pagtalunan; P L Miller; S Jumping-Eagle; R G Nelson; B D Myers; H G Rennke; N S Coplon; L Sun; T W Meyer
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 7.  Glomerular epithelial stem cells: the good, the bad, and the ugly.

Authors:  Laura Lasagni; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 10.121

8.  Regeneration of glomerular podocytes by human renal progenitors.

Authors:  Elisa Ronconi; Costanza Sagrinati; Maria Lucia Angelotti; Elena Lazzeri; Benedetta Mazzinghi; Lara Ballerini; Eliana Parente; Francesca Becherucci; Mauro Gacci; Marco Carini; Enrico Maggi; Mario Serio; Gabriella Barbara Vannelli; Laura Lasagni; Sergio Romagnani; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

9.  Urinary excretion of viable podocytes in health and renal disease.

Authors:  Stefanie U Vogelmann; W James Nelson; Bryan D Myers; Kevin V Lemley
Journal:  Am J Physiol Renal Physiol       Date:  2003-03-11

Review 10.  Toward the identification of a "renopoietic system"?

Authors:  Paola Romagnani
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more
  11 in total

1.  Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin.

Authors:  Manga Motrapu; Monika Katarzyna Świderska; Irene Mesas; Julian Aurelio Marschner; Yutian Lei; Laura Martinez Valenzuela; Jia Fu; Kyung Lee; Maria Lucia Angelotti; Giulia Antonelli; Paola Romagnani; Hans-Joachim Anders; Lidia Anguiano
Journal:  J Am Soc Nephrol       Date:  2020-06-23       Impact factor: 10.121

2.  Excretion Patterns of Urinary Sediment and Supernatant Podocyte Biomarkers in Patients with CKD.

Authors:  Akihiro Fukuda; Akihiro Minakawa; Yuji Sato; Hirotaka Shibata; Masanori Hara; Shouichi Fujimoto
Journal:  Kidney360       Date:  2021-11-05

3.  Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.

Authors:  Yoko Shirai; Kenichiro Miura; Takashi Yokoyama; Shigeru Horita; Hideki Nakayama; Hiroshi Seino; Taro Ando; Atsutoshi Shiratori; Tomoo Yabuuchi; Naoto Kaneko; Sho Ishiwa; Kiyonobu Ishizuka; Masanori Hara; Motoshi Hattori
Journal:  Kidney360       Date:  2020-12-01

Review 4.  Modes of podocyte death in diabetic kidney disease: an update.

Authors:  Anni Jiang; Anni Song; Chun Zhang
Journal:  J Nephrol       Date:  2022-02-24       Impact factor: 4.393

5.  Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy.

Authors:  Akihiro Minakawa; Akihiro Fukuda; Yuji Sato; Masao Kikuchi; Kazuo Kitamura; Roger C Wiggins; Shouichi Fujimoto
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

6.  Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy.

Authors:  Yan Chen; Qingpu Liu; Zengfu Shan; Wangyang Mi; Yingying Zhao; Meng Li; Baiyan Wang; Xiaoke Zheng; Weisheng Feng
Journal:  Front Pharmacol       Date:  2019-12-10       Impact factor: 5.810

7.  Diabetic condition induces hypertrophy and vacuolization in glomerular parietal epithelial cells.

Authors:  Takahisa Kawaguchi; Kazuhiro Hasegawa; Itaru Yasuda; Hirokazu Muraoka; Hiroyuki Umino; Hirobumi Tokuyama; Akinori Hashiguchi; Shu Wakino; Hiroshi Itoh
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

8.  Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway.

Authors:  Fujing Wang; Jia'er Fan; Tingting Pei; Zhuo'en He; Jiaxing Zhang; Liliang Ju; Zhongxiao Han; Mingqing Wang; Wei Xiao
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

9.  The sponging effect of a lncRNA on a miRNA contributes to diabetic nephropathy.

Authors:  Anil K Pasupulati; Atreya S V Paturi
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-30       Impact factor: 8.886

10.  Association between Renal Podocalyxin Expression and Renal Dysfunction in Patients with Diabetic Nephropathy: A Single-Center, Retrospective Case-Control Study.

Authors:  Rongzhen Wang; Can Yao; Feng Liu
Journal:  Biomed Res Int       Date:  2020-04-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.